Asia Pacific Deep Brain Simulation Market Forecast to 2030

Asia Pacific Deep Brain Simulation Market Forecast to 2030 – Regional Analysis – by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson’s Disease, Tremor, Dystonia, Epilepsy, Alzheimer’s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)

Send Enquiry
Item ID: BMIRE00029018 Category: Tags: , ,

$2,100$3,500

Description

The Asia Pacific deep brain simulation market is expected to grow from US$ 98.35 million in 2022 to US$ 188.04 million by 2030. It is estimated to grow at a CAGR of 8.4% from 2022 to 2030.

Technological Advancements and Approvals in Deep Brain Stimulation Drive Asia Pacific Deep Brain Simulation Market

Robotic implantation, multi-target stimulation, improved microelectrode designs, rechargeable pulse generators, and personalized, targeted programming are among the technological advancements in deep brain stimulation (DBS). Owing to these advancements, DBS devices show fewer side effects and improved efficacy and symptom relief in Parkinson’s patients compared to traditional methods. Abbott’s Infinity Deep Brain Stimulation System is a technologically advanced new DBS that helps the patients manage their symptoms. It is the first wireless iOS software DBS mobile platform that has offered efficient and personalized therapy management with reduced risk of side effects. According to the MGM Healthcare press release published in February 2020, MGM Healthcare, Tamil Nadu, performed its first deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD). Therefore, technological advancements in DBS are expected to create opportunities for the Asia Pacific deep brain stimulation market during the forecast period.

Asia Pacific Deep Brain Simulation Market Overview

China is home to the world’s largest population of older adults. According to a study published in The Lancet titled “China’s Aging Population: Crisis or Opportunity?” in 2019, people in China aged 60 or older were ~254 million. By 2040, that number is expected to rise to 402 million, ~28% of the population. These changes have profound public health implications in the country as the risk and burden of noncommunicable diseases increase along with the demand for health and social care systems. Parkinson’s disease (PD) is a common neurodegenerative disease in the country. According to ChinaDaily, there were approximately 4 million Parkinson’s patients in China as of February 2023, and ~1.7% of people over 65 years have been diagnosed with the disease. According to a study discussed in the Journal of Health, Population, and Nutrition, the number of people with Alzheimer’s disease in China is ~6 million, with dementia rates among 65-, 75-, and 85-year-olds being 5%, 11.5%, and 30%, respectively. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is effective in the treatment of Parkinson’s disease (PD). With advancements in DBS hardware, researchers have developed several novel programming technologies, of which remote programming is widely used in China. Since 2018, we have been performing remote programming for patients suffering from PD using PINS products (PINS Medical, Ltd., Beijing, China). For patients with advanced Parkinson’s disease (over a 15-year time horizon), DBS is considered to be a highly effective treatment option. However, DBS remains a significant economic burden on the patient when not reimbursed, unlike in any other developed country. In China, the surgery cost is mainly covered by the patient’s health insurance, but the cost of DBS hardware is only partially covered, which can hamper the growth of the market in the country.

Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Deep Brain Simulation Market Segmentation

The Asia Pacific deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the Asia Pacific deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on application, the Asia Pacific deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on end user, the Asia Pacific deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Asia Pacific deep brain simulation market.

Based on country, the Asia Pacific deep brain simulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. In 2022, China segment registered the largest share in the Asia Pacific deep brain simulation market.

Abbott Laboratories, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Medtronic Plc, and SceneRay Co Ltd are some of the leading companies operating in the Asia Pacific deep brain simulation market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 8.4% CAGR, the Asia Pacific Deep Brain Simulation Market is Speculated to be worth US$ 188.04 million by 2030, saysthe research team

According tothe research team Market research, the Asia Pacific deep brain simulation market was valued at US$ 98.35 million in 2022 and is expected to reach US$ 188.04 million by 2030, registering a CAGR of 8.4% from 2022 to 2030. Increasing demand for minimally invasive surgery and technological advancements and approvals in deep brain stimulation are the critical factors attributed to the Asia Pacific deep brain simulation market expansion.

Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson’s disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the deep brain stimulation (DBS) market growth.

On the contrary, side effects associated with deep brain stimulation hurdles the growth of Asia Pacific deep brain simulation market.

Based on product, the Asia Pacific deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 48.8% share of Asia Pacific deep brain simulation market in 2023, amassing US$ 47.97 million. It is projected to garner US$ 98.65 million by 2030 to expand at 9.4% CAGR during 2022–2030.

Based on application, the Asia Pacific deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. The Parkinson’s disease segment held 68.2% share of Asia Pacific deep brain simulation market in 2023, amassing US$ 77.33 million. It is projected to garner US$ 147.16 million by 2030 to expand at 8.4% CAGR during 2022–2030.

Based on end user, the Asia Pacific deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 59.7% share of Asia Pacific deep brain simulation market in 2022, amassing US$ 58.74 million. It is projected to garner US$ 117.45 million by 2030 to expand at 9.0% CAGR during 2022–2030.

Based on country, the Asia Pacific deep brain simulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 40.3% share of Asia Pacific deep brain simulation market in 2022. It was assessed at US$ 39.61 million in 2022 and is likely to hit US$ 82.73 million by 2030, exhibiting a CAGR of 9.6% during 2022–2030.

Key players operating in the Asia Pacific deep brain simulation market report Abbott Laboratories, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Medtronic Plc, and SceneRay Co Ltd, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Asia Pacific Deep Brain Stimulation Market, by Region (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Deep Brain Simulation Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 Asia Pacific Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. Asia Pacific Deep Brain Simulation Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. Deep Brain Simulation Market – Asia Pacific Market Analysis
6.1 Asia Pacific Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson’s Disease
8.3.1 Overview
8.3.2 Parkinson’s Disease: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s Disease
8.5.1 Overview
8.5.2 Alzheimer’s Disease: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Asia Pacific Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Deep Brain Simulation Market – Country Analysis
10.1 Overview
10.1.1.1 Asia Pacific Deep Brain Simulation Market by Country
10.1.1.2 China
10.1.1.2.1 Overview
10.1.1.2.2 China Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 China Deep Brain Simulation Market, by Product
10.1.1.2.4 China Deep Brain Simulation Market, by Application
10.1.1.2.5 China Deep Brain Simulation Market, by End User
10.1.1.3 Japan
10.1.1.3.1 Overview
10.1.1.3.2 Japan Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Japan Deep Brain Simulation Market, by Product
10.1.1.3.4 Japan Deep Brain Simulation Market, by Application
10.1.1.3.5 Japan Deep Brain Simulation Market, by End User
10.1.1.4 India
10.1.1.4.1 Overview
10.1.1.4.2 India Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 India Deep Brain Simulation Market, by Product
10.1.1.4.4 India Deep Brain Simulation Market, by Application
10.1.1.4.5 India Deep Brain Simulation Market, by End User
10.1.1.5 Australia
10.1.1.5.1 Overview
10.1.1.5.2 Australia Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Australia Deep Brain Simulation Market, by Product
10.1.1.5.4 Australia Deep Brain Simulation Market, by Application
10.1.1.5.5 Australia Deep Brain Simulation Market, by End User
10.1.1.6 South Korea
10.1.1.6.1 Overview
10.1.1.6.2 South Korea Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 South Korea Deep Brain Simulation Market, by Product
10.1.1.6.4 South Korea Deep Brain Simulation Market, by Application
10.1.1.6.5 South Korea Deep Brain Simulation Market, by End User
10.1.1.7 Rest of Asia Pacific
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Asia Pacific Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Asia Pacific Deep Brain Simulation Market, by Product
10.1.1.7.4 Rest of Asia Pacific Deep Brain Simulation Market, by Application
10.1.1.7.5 Rest of Asia Pacific Deep Brain Simulation Market, by End User
11. Pre & Post Covid-19 Impact
11.1 Pre & Post Covid-19 Impact
12. Asia Pacific Deep Brain Simulation Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in Deep Brain Stimulation Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Deep Brain Simulation Market, Key Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Beijing PINS Medical Co Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 SceneRay Co Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Deep Brain Simulation Market Segmentation
Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
Table 3. Asia Pacific Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
Table 4. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 5. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 7. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 8. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 9. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 10. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 11. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 12. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 13. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 14. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 15. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 16. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 17. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 18. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 19. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 20. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 21. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Recent Organic Growth Strategies in Deep Brain Stimulation Market
Table 23. Recent Inorganic Growth Strategies in the Asia Pacific deep brain simulation market
Table 24. Glossary of Terms, Asia Pacific Deep Brain Simulation Market

LIST OF FIGURES

Figure 1. Asia Pacific Deep Brain Simulation Market Segmentation, By Country
Figure 2. Asia Pacific – PEST Analysis
Figure 3. Asia Pacific Deep Brain Simulation Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Asia Pacific Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Single Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Dual Channel Deep Brain Stimulator: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Accessories: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Asia Pacific Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Parkinson’s Disease: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Tremor: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alzheimer’s Disease: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dystonia: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Asia Pacific Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurology Clinics: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific Deep Brain Simulation Market, By Country, 2022 ($Mn)
Figure 23. Asia Pacific Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
Figure 24. China Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Japan Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. India Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Australia Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. South Korea Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 29. Rest of Asia Pacific Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 30. Pre & Post Covid-19 Impact
Figure 31. Growth Strategies in Deep Brain Stimulation Market

The List of Companies – Asia Pacific Deep Brain Simulation Market

– Abbott Laboratories
– Beijing PINS Medical Co Ltd
– Boston Scientific Corp
– Medtronic Plc
– SceneRay Co Ltd

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Deep Brain Simulation Market Forecast to 2030”